Staying engaged during your healing journey is important for a successful outcome.

Make sure you download the EXOGEN Connects app and check out the EXOGEN Performance program.

It’s Time to Heal


At your side 24/7, keeping you connected during your healing journey

EXOGEN CONNECTS is our free smartphone app that automatically sends daily reminders to help you stay on track with your 20-minute a day treatment schedule.

It’s easy to download and activate from your app store, and includes helpful tips and information to promote better healing results.

Let EXOGEN CONNECTS help you stay on the road to faster, better healing.


EXOGEN Performance Program

The EXOGEN Performance Program is a Bioventus program that refunds the payment for EXOGEN if progression of healing (progression to bony union) is not shown per criteria below. The program is also designed to help reinforce patients’ adherence with the prescribed treatment.

Buyers of EXOGEN participating in the program are eligible when the device has been prescribed by a qualified physician to treat a stable, well-aligned fracture with a fracture gap less than 10 millimeters (excluding vertebra and skull fractures). Patients must treat their fracture with EXOGEN per product instructions, for a minimum of 120 consecutive days and achieve a 90% minimum level of adherence.

To be eligible, your prescribing physician must determine that your bone has not healed, or progressed to a bony union after 120 consecutive days or more of EXOGEN treatment. This evaluation must be based on X-rays taken prior to and after the patient’s treatment with EXOGEN.

The EXOGEN device contains an internal patient usage monitor that records the date, time and duration of each treatment session must be returned with the claim. This monitor will be used by Bioventus to confirm that at least 90% treatment adherence is met.


  • Fracture types:
      • Unstable
      • Malaligned fracture
      • Greater than 10 millimeters fracture gap
      • Vertebra and skull
      • Pathological
  • Treatment of multiple fractures locations (the guarantee is only valid to treat a defined fracture)
  • Modified and/or altered devices
  • Alternative interventions occurred during the 120-day treatment period
  • EXOGEN devices that were not purchased and received directly from Bioventus
  • Customers who did not register to the EXOGEN Performance Program within the first 30 days of the initial treatment
  • Patient who was not prescribed treatment with EXOGEN
  • Other costs associated with the purchase (only the cost of the EXOGEN device will be refunded)
  • Valid only in the United Kingdom and Ireland

You may contact Bioventus Customer Care for Assistance.

Claims must be received by Bioventus within one year of the fist EXOGEN treatment date.

Bioventus reserves the right to amend or cancel the program at any time.

Social Media

Follow along to see your recovery stories and get the latest from EXOGEN

We're Here For You

Bioventus Customer Service is available to answer your questions and help you stay consistent with your EXOGEN treatment schedule.
For Bioventus Customer Service, call 0800 05 16 384.

Summary of Indications for Use
EXOGEN is indicated for the non-invasive treatment of osseous defects (excluding vertebra and skull) that includes the treatment of delayed unions, nonunions,* stress fractures and joint fusion. EXOGEN is also indicated for the acceleration of fresh fracture heal time, repair following osteotomy, repair in bone transport procedures and repair in distraction osteogenesis procedures.

There are no known contraindications for the EXOGEN device. Safety and effectiveness have not been established for individuals lacking skeletal maturity, pregnant or nursing women, patients with cardiac pacemakers, on fractures due to bone cancer, or on patients with poor blood circulation or clotting problems. Some patients may be sensitive to the ultrasound gel.

Full prescribing information can be found in product labeling, at, or by calling Bioventus Customer Service.

*A nonunion is considered to be established when the fracture site shows no visibly progressive signs of healing.